LymphopeniaNeutropeniaT-Lymphocytopenia, Idiopathic CD4-PositiveAgranulocytosisFebrile NeutropeniaFeverChemotherapy-Induced Febrile NeutropeniaAntineoplastic Combined Chemotherapy ProtocolsLeukocyte CountGranulocyte Colony-Stimulating FactorCarboprostDrug Administration ScheduleLymphocyte CountPropylene GlycolsRats, Inbred BBTreatment OutcomeLeukopeniaOpportunistic InfectionsInfusions, IntravenousLeukocytosisMaximum Tolerated DoseThrombocytopeniaTaxoidsNeoplasmsPaclitaxelAntineoplastic AgentsBlood Cell CountNeutrophilsLymphocytesHematologic DiseasesCamptothecinT-LymphocytesSevere Combined ImmunodeficiencyReceptors, LysosphingolipidInterleukin-7Dose-Response Relationship, DrugImmunocompromised HostDeoxycytidineAntineoplastic Agents, AlkylatingDacarbazineImmunologic Deficiency SyndromesAntineoplastic Agents, PhytogenicCyclophosphamideCisplatinBone MarrowFelty SyndromeLeukocyte ElastaseSurvival AnalysisFluorouracilMycosesSphingosineDisease-Free SurvivalSurvival RateVinblastineRetrospective StudiesCD4-Positive T-LymphocytesFood Coloring AgentsThymus GlandImmunosuppressive AgentsRecombinant ProteinsTime FactorsReceptors, Granulocyte Colony-Stimulating FactorCarboplatinLymphocyte SubsetsFever of Unknown OriginCombined Modality TherapyDoxorubicinT-Lymphocyte SubsetsOrganoplatinum CompoundsFlow CytometryLeucovorinBacterial InfectionsAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisAntibodies, MonoclonalTopotecanSpleenLung NeoplasmsHematologic NeoplasmsProspective StudiesLupus Erythematosus, SystemicAntibodies, Monoclonal, HumanizedMice, Inbred C57BLLymphopoiesisNauseaB-LymphocytesEtoposideHomeostasisDisease ProgressionEpirubicinHematopoiesisLupus Vasculitis, Central Nervous SystemLymphocyte DepletionSalvage TherapyT-Lymphocytes, RegulatoryAdoptive TransferCD8-Positive T-LymphocytesLymphocyte ActivationCell ProliferationAntimetabolites, AntineoplasticNeoplasm Metastasis